Although TRPC1 expression contributes to various tumor outcomes, its over expression is predominantly and most consistently correlated with poor cancer outcomes in lung, pancreatic, breast, glioblastoma multiforme, and colon cancers [24,48,49,50,51,52]. The gene discussed is TRPC1; the disease is glioblastoma.